Empiric outpatient therapy with trimethoprim-sulfamethoxazole, cephalexin, or clindamycin for cellulitis

American Journal of Medicine

Volumn 123, Issue 10, 2010, Pages 942-950

  Khawcharoenporn, Thana ^a   Tice, Alan ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Cellulitis; Empiric; Oral antibiotics; Outpatients; Treatment; Wound infection

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFALEXIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DICLOXACILLIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; MOXIFLOXACIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CELLULITIS; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG ERUPTION; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NAUSEA; OUTPATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRURITUS; RISK FACTOR; TERTIARY HEALTH CARE; TREATMENT FAILURE; TREATMENT OUTCOME; ADOLESCENT; COMPARATIVE STUDY; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CELLULITIS; CEPHALEXIN; CLINDAMYCIN; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

EID: 77957766934     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.05.020     Document Type: Article

References (20)

1. S.M. Ellis Simonsen, E.R. van Orman, and B.E. Hatch Cellulitis incidence in a defined population Epidemiol Infect 134 2006 293 299
2. D.L. Stevens, A.L. Bisno, and H.F. Chambers Practice guidelines for the diagnosis and management of skin and soft-tissue infections Clin Infect Dis 41 2005 1373 1406
3. S. Deresinski Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey Clin Infect Dis 40 2005 562 573
4. G.J. Moran, A. Krishnadasan, and R.J. Gorwitz Methicillin-resistant Staphylococcus aureus infections among patients in the emergency department N Engl J Med 355 2006 666 674
5. Centers for Disease Control and Prevention Community-associated methicillin-resistant Staphylococcus aureus infections in Pacific Islanders-Hawaii, 2001-2003 MMWR Morb Mortal Wkly Rep 53 2004 767 770
6. C.F. Estivariz, S.Y. Park, and J.C. Hageman Emergence of community-associated methicillin resistant Staphylococcus aureus in Hawaii, 2001-2003 J Infect 54 2007 349 357
7. Tice A, Thorson P, Eischen M, et al. An epidemic of methicillin-resistant Staphylococcus aureus among the Homeless of Hawaii (abstract 870). In: the 47th Infectious Diseases Society of America 2009, October 2009, Philadelphia, PA.
8. M.N. Swartz Clinical practice Cellulitis N Engl J Med 350 2004 904 912
9. J.J. Ruhe, N. Smith, R.W. Bradsher, and A. Menon Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome Clin Infect Dis 44 2007 777 784
10. J.J. Ruhe, and A. Menon Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus Antimicrob Agents Chemother 51 2007 3298 3303
11. J.D. Szumowski, D.E. Cohen, F. Kanaya, and K.H. Mayer Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic Antimicrob Agents Chemother 51 2007 423 428
12. National Kidney Foundation The National Kidney Foundation Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2002 S1 S266
13. Clinical and Laboratory Standards Institute (CLSI) METHODS: for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically Approved standard M7-A7 7th ed. 2006 CLSI Wayne, PA
14. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing Sixteenth informational supplement M100-S16 2006 CLSI Wayne, PA
15. T. Khawcharoenporn, and A. Tice Oral antibiotic treatment for methicillin-resistant Staphylococcus aureus skin and soft tissue infections: review of the literature Hawaii Med J 65 2006 290 293
16. K.J. Madaras-Kelly, R.E. Remington, and C.M. Oliphant Efficacy of oral beta-lactam versus non-beta-lactam treatment of uncomplicated cellulitis Am J Med 121 2008 419 425
17. G.N. Al-Rawahi, S. Reynolds, and S.D. Porter Community-associated CMRSA-10 (USA-300) is the predominant strain among methicillin-resistant Staphylococcus aureus strains causing skin and soft tissue infections in patients presenting to the emergency department of a Canadian tertiary care hospital J Emerg Med 38 2010 6 11
18. S.V. Kazakova, J.C. Hageman, and M. Matava A clone of methicillin-resistant Staphylococcus aureus among professional football players N Engl J Med 352 2005 468 475
19. Khawcharoenporn T, Tice AD, Grandinetii A, Chow D. Risk factors for community-associated methicillin-resistant Staphylococcus aureus cellulitis and the value of recognition. Hawaii Med J. (In press).
20. F.M. Abrahamian, and E.W. Snyder Community-associated Methicillin-resistant Staphylococcus aureus: incidence, clinical presentation, and treatment decisions Curr Infect Dis Rep 9 2007 391 397